Psychiatric Adverse Reactions with Statins, Fibrates and Ezetimibe: Implications for the Use of Lipid-Lowering Agents

ISSN： 0114-5916

Source： Drug Safety, Vol.30, Iss.3, 2007-01, pp. : 195-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New lipid-lowering agents

By Wierzbicki Anthony S

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 365-376

Informa Healthcare

Access to resources Recommend Favorite

A New Class of Lipid-Lowering Drugs: Ezetimibe

Heart Drug, Vol. 3, Iss. 4, 2004-02 ,pp. : 214-216

Karger

Access to resources Recommend Favorite

The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels

By Dierkes Jutta Westphal Sabine Luley Claus

Expert Opinion on Drug Safety, Vol. 3, Iss. 2, 2004-03 ,pp. : 101-111

Informa Healthcare

Access to resources Recommend Favorite

Interactions between cyclosporin and lipid-lowering agents

Inpharma, Vol. 1, Iss. 1381, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Lipid-lowering agents and new onset diabetes mellitus

By Athyros Vasilios G Tziomalos Konstantinos Karagiannis Asterios Mikhailidis Dimitri P

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 12, 2010-08 ,pp. : 1965-1970

Informa Healthcare

Access to resources Recommend Favorite